About iWound
iWound is a company based in Oshawa (Canada) founded in 2020. It operates as a B2B and B2C. iWound offers products and services including i-Coll® Bioactive Collagen Particles and i-Coll® Matrix Dry Absorbable Collagen Sheets. iWound operates in a competitive market with competitors including DOMO Health, HeartLab, PredictImmune, EMGuidance and Zhongzhi Daxin Technology, among others.
- Annual Revenue₹76.6 Lakh
FY 2025
- Net Loss-₹45.3 Lakh
FY 2025 · -59% margin
- EBITDA-₹44 Lakh
FY 2025 · -57% margin
Associated legal entities of iWound
iWound operates through Iwound Global Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Iwound Global Private Limited CIN U46497TN2023FTC166312 | Active | 28 Dec 2023 | Chennai, Tamil Nadu | ₹0.8 Cr | – | 2 | View details |
Products & Services of iWound
iWound offers a comprehensive portfolio of products and services, including i-Coll® Bioactive Collagen Particles and i-Coll® Matrix Dry Absorbable Collagen Sheets.
Particles that promote fast healing for skin tears and chronic wounds.
Sheets designed for treating venous ulcers and various wound types.
Board of directors of Iwound Global Private Limited (iWound)
Iwound Global Private Limited is the primary company behind iWound. The board of Iwound Global Private Limited currently have 2 directors; the longest-serving is Anish Makim, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anish Makim DIN 10442403 | Non- Individual Subscriber | 28 Dec 2023 | 2 yrs 9 mo | Iwound Global Private Limited |
| Joseph Selvamjosephwatts DIN 10442404 | Managing Director | 28 Dec 2023 | 2 yrs 9 mo | Iwound Global Private Limited |
Financials of iWound
Figures of Iwound Global Private Limited, the primary company behind iWound, for FY 2025. Revenue was ₹76.6 Lakh. Net loss was -₹45.3 Lakh (-59% margin). EBITDA was -₹44 Lakh (-57% margin).
- ₹76.6 LakhRevenue · FY 2025
- -₹45.3 LakhNet loss · -59% margin
- -₹44 LakhEBITDA · -57% margin
- ₹36 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Iwound Global Private Limited are on its company page.
Detailed financial statements for iWound
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of iWound
iWound operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DOMO Health, HeartLab, PredictImmune, EMGuidance and Zhongzhi Daxin Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| domo.health | 2012 | Lausanne, Switzerland | $19.38M | – | Cloud and AI-based data analysis tool for providers | |
| heartlab.com | 2018 | Auckland, New Zealand | $2.48M | – | Cloud-based echocardiography data analysis is provided to healthcare providers. | |
| predictimmune.com | 2017 | Cambridge, United Kingdom | $18.32M | 15 | Tools for diagnosing immune-mediated inflammatory diseases are developed. | |
| emguidance.com | 2016 | Johannesburg, South Africa | – | – | Web-based solution that provides access to relevant medicines information | |
| bjzzdx.com | 2014 | Guangzhou, China | – | – | AI solutions for surgical procedures and record management are provided. | |
| parallaxhealthsciences.com | 2005 | Santa Monica, United States | $1.1M | 6 | Digital health diagnosis tools are provided for healthcare professionals. | |
| aspicinnovations.com | 2021 | Kolkata, India | – | – | Healthcare product development and training services are provided to clients. | |
| medicim.com | 2002 | Mechelen, Belgium | – | 141 | Creates dental software solutions through innovation and teamwork. | |
| chikitsak.in | 2015 | Bengaluru, India | – | 57 | Provides healthcare diagnostics using Bluetooth-enabled products. |
Detailed competitors of iWound
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to iWound
10 companies that operate in the same segment as iWound (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about iWound
iWound was founded in 2020.
iWound is headquartered in Oshawa, Canada. It is registered at Oshawa, Ontario, Canada.
The primary company behind iWound, Iwound Global Private Limited, reported revenue of ₹76.6 Lakh for FY 2025.
iWound Global specializes in advanced wound care therapies, focusing on collagen products like i-Coll particles and sheets to accelerate healing for hard-to-heal wounds. The company operates with a patient-centric approach, providing comprehensive education and support. Based in Chennai, India, they partner with healthcare facilities to improve outcomes, empowering individuals through reliable healing solutions and testimonials from users.
iWound's top competitors include EMGuidance, PredictImmune and Chkitsak.
iWound offers i-Coll® Bioactive Collagen Particles and i-Coll® Matrix Dry Absorbable Collagen Sheets.
iWound operates through Iwound Global Private Limited.
The legal entities of iWound currently have 2 directors, including Anish Makim, Joseph Selvamjosephwatts.